Skip to main content
. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306

Figure 2.

Figure 2

Neutralizing antibody (A) and IgG antibodies against the spike receptor-binding domain of SARS-CoV-2 (B). This is an antibody titer analyzed at visit 2 (4 weeks after 1st vaccination), visit 3 (3 months after 2nd vaccination), and visit 4 (6 months after 2nd vaccination). Diamond marks were represented as mean values.